| Yezi Zhang, MD | |
|
330 E Warwick Dr, Alma, MI 48801-1014 | |
| (989) 629-8140 | |
| (989) 629-8145 |
| Full Name | Yezi Zhang |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 8 Years |
| Location | 330 E Warwick Dr, Alma, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760910137 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 4301112551 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Midmichigan Medical Center-midland | Midland, MI | Hospital |
| Midmichigan Medical Center-clare | Clare, MI | Hospital |
| Midmichigan Medical Center-west Branch | West branch, MI | Hospital |
| Midmichigan Medical Center-gladwin | Gladwin, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mymichigan Medical Group | 4981501939 | 162 |
News Archive
An enzyme that helps break down cholesterol may also be a therapeutic target to stave off neurologic diseases, including Alzheimer's and a rare genetic disorder, according to a new study published in the Journal of Biological Chemistry.
Mylan Inc. today announced that its partner Biocon has received approval for a Mylan-Biocon trastuzumab product from the Drug Controller General of India. This is the first regulatory approval for a Mylan-Biocon developed biosimilar product.
Adult stem cells may help repair heart tissue damaged by heart attack according to the findings of a new study to be published in the December 8 issue of the Journal of the American College of Cardiology. Results from the Phase I study show stem cells from donor bone marrow appear to help heart attack patients recover better by growing new blood vessels to bring more oxygen to the heart.
BrainCool AB, a Swedish medical device innovator, and a world leader in medical cooling technology for therapeutic hypothermia (brain cooling) and oncology, is pleased to announce that it has completed patient recruitment in the Scandinavian multi-center pivotal trial of 180 patients to investigate the patented Cooral® System for prevention of Oral Mucositis, one of the most debilitating side-effects of both standard and high-dose chemotherapeutic oncology treatments.
Per- and polyfluorinated alkyl substances are man-made chemicals that are useful in a variety of industries because of their durability, but do not naturally break down in the environment or human body.
› Verified 3 days ago
| Entity Name | Mymichigan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740230127 PECOS PAC ID: 4981501939 Enrollment ID: O20040126000905 |
News Archive
An enzyme that helps break down cholesterol may also be a therapeutic target to stave off neurologic diseases, including Alzheimer's and a rare genetic disorder, according to a new study published in the Journal of Biological Chemistry.
Mylan Inc. today announced that its partner Biocon has received approval for a Mylan-Biocon trastuzumab product from the Drug Controller General of India. This is the first regulatory approval for a Mylan-Biocon developed biosimilar product.
Adult stem cells may help repair heart tissue damaged by heart attack according to the findings of a new study to be published in the December 8 issue of the Journal of the American College of Cardiology. Results from the Phase I study show stem cells from donor bone marrow appear to help heart attack patients recover better by growing new blood vessels to bring more oxygen to the heart.
BrainCool AB, a Swedish medical device innovator, and a world leader in medical cooling technology for therapeutic hypothermia (brain cooling) and oncology, is pleased to announce that it has completed patient recruitment in the Scandinavian multi-center pivotal trial of 180 patients to investigate the patented Cooral® System for prevention of Oral Mucositis, one of the most debilitating side-effects of both standard and high-dose chemotherapeutic oncology treatments.
Per- and polyfluorinated alkyl substances are man-made chemicals that are useful in a variety of industries because of their durability, but do not naturally break down in the environment or human body.
› Verified 3 days ago
| Entity Name | Mymichigan Medical Center Alma |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265596126 PECOS PAC ID: 3375451404 Enrollment ID: O20040202000975 |
News Archive
An enzyme that helps break down cholesterol may also be a therapeutic target to stave off neurologic diseases, including Alzheimer's and a rare genetic disorder, according to a new study published in the Journal of Biological Chemistry.
Mylan Inc. today announced that its partner Biocon has received approval for a Mylan-Biocon trastuzumab product from the Drug Controller General of India. This is the first regulatory approval for a Mylan-Biocon developed biosimilar product.
Adult stem cells may help repair heart tissue damaged by heart attack according to the findings of a new study to be published in the December 8 issue of the Journal of the American College of Cardiology. Results from the Phase I study show stem cells from donor bone marrow appear to help heart attack patients recover better by growing new blood vessels to bring more oxygen to the heart.
BrainCool AB, a Swedish medical device innovator, and a world leader in medical cooling technology for therapeutic hypothermia (brain cooling) and oncology, is pleased to announce that it has completed patient recruitment in the Scandinavian multi-center pivotal trial of 180 patients to investigate the patented Cooral® System for prevention of Oral Mucositis, one of the most debilitating side-effects of both standard and high-dose chemotherapeutic oncology treatments.
Per- and polyfluorinated alkyl substances are man-made chemicals that are useful in a variety of industries because of their durability, but do not naturally break down in the environment or human body.
› Verified 3 days ago
| Entity Name | Mymichigan Medical Center Midland |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205889490 PECOS PAC ID: 2264323633 Enrollment ID: O20040324000137 |
News Archive
An enzyme that helps break down cholesterol may also be a therapeutic target to stave off neurologic diseases, including Alzheimer's and a rare genetic disorder, according to a new study published in the Journal of Biological Chemistry.
Mylan Inc. today announced that its partner Biocon has received approval for a Mylan-Biocon trastuzumab product from the Drug Controller General of India. This is the first regulatory approval for a Mylan-Biocon developed biosimilar product.
Adult stem cells may help repair heart tissue damaged by heart attack according to the findings of a new study to be published in the December 8 issue of the Journal of the American College of Cardiology. Results from the Phase I study show stem cells from donor bone marrow appear to help heart attack patients recover better by growing new blood vessels to bring more oxygen to the heart.
BrainCool AB, a Swedish medical device innovator, and a world leader in medical cooling technology for therapeutic hypothermia (brain cooling) and oncology, is pleased to announce that it has completed patient recruitment in the Scandinavian multi-center pivotal trial of 180 patients to investigate the patented Cooral® System for prevention of Oral Mucositis, one of the most debilitating side-effects of both standard and high-dose chemotherapeutic oncology treatments.
Per- and polyfluorinated alkyl substances are man-made chemicals that are useful in a variety of industries because of their durability, but do not naturally break down in the environment or human body.
› Verified 3 days ago
| Entity Name | Mymichigan Medical Center Clare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225081862 PECOS PAC ID: 7012829773 Enrollment ID: O20040720000582 |
News Archive
An enzyme that helps break down cholesterol may also be a therapeutic target to stave off neurologic diseases, including Alzheimer's and a rare genetic disorder, according to a new study published in the Journal of Biological Chemistry.
Mylan Inc. today announced that its partner Biocon has received approval for a Mylan-Biocon trastuzumab product from the Drug Controller General of India. This is the first regulatory approval for a Mylan-Biocon developed biosimilar product.
Adult stem cells may help repair heart tissue damaged by heart attack according to the findings of a new study to be published in the December 8 issue of the Journal of the American College of Cardiology. Results from the Phase I study show stem cells from donor bone marrow appear to help heart attack patients recover better by growing new blood vessels to bring more oxygen to the heart.
BrainCool AB, a Swedish medical device innovator, and a world leader in medical cooling technology for therapeutic hypothermia (brain cooling) and oncology, is pleased to announce that it has completed patient recruitment in the Scandinavian multi-center pivotal trial of 180 patients to investigate the patented Cooral® System for prevention of Oral Mucositis, one of the most debilitating side-effects of both standard and high-dose chemotherapeutic oncology treatments.
Per- and polyfluorinated alkyl substances are man-made chemicals that are useful in a variety of industries because of their durability, but do not naturally break down in the environment or human body.
› Verified 3 days ago
| Entity Name | Mymichigan Medical Center Gladwin |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881869774 PECOS PAC ID: 0143262915 Enrollment ID: O20081024000094 |
News Archive
An enzyme that helps break down cholesterol may also be a therapeutic target to stave off neurologic diseases, including Alzheimer's and a rare genetic disorder, according to a new study published in the Journal of Biological Chemistry.
Mylan Inc. today announced that its partner Biocon has received approval for a Mylan-Biocon trastuzumab product from the Drug Controller General of India. This is the first regulatory approval for a Mylan-Biocon developed biosimilar product.
Adult stem cells may help repair heart tissue damaged by heart attack according to the findings of a new study to be published in the December 8 issue of the Journal of the American College of Cardiology. Results from the Phase I study show stem cells from donor bone marrow appear to help heart attack patients recover better by growing new blood vessels to bring more oxygen to the heart.
BrainCool AB, a Swedish medical device innovator, and a world leader in medical cooling technology for therapeutic hypothermia (brain cooling) and oncology, is pleased to announce that it has completed patient recruitment in the Scandinavian multi-center pivotal trial of 180 patients to investigate the patented Cooral® System for prevention of Oral Mucositis, one of the most debilitating side-effects of both standard and high-dose chemotherapeutic oncology treatments.
Per- and polyfluorinated alkyl substances are man-made chemicals that are useful in a variety of industries because of their durability, but do not naturally break down in the environment or human body.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yezi Zhang, MD 330 E Warwick Dr, Alma, MI 48801-1014 Ph: (989) 629-8140 | Yezi Zhang, MD 330 E Warwick Dr, Alma, MI 48801-1014 Ph: (989) 629-8140 |
News Archive
An enzyme that helps break down cholesterol may also be a therapeutic target to stave off neurologic diseases, including Alzheimer's and a rare genetic disorder, according to a new study published in the Journal of Biological Chemistry.
Mylan Inc. today announced that its partner Biocon has received approval for a Mylan-Biocon trastuzumab product from the Drug Controller General of India. This is the first regulatory approval for a Mylan-Biocon developed biosimilar product.
Adult stem cells may help repair heart tissue damaged by heart attack according to the findings of a new study to be published in the December 8 issue of the Journal of the American College of Cardiology. Results from the Phase I study show stem cells from donor bone marrow appear to help heart attack patients recover better by growing new blood vessels to bring more oxygen to the heart.
BrainCool AB, a Swedish medical device innovator, and a world leader in medical cooling technology for therapeutic hypothermia (brain cooling) and oncology, is pleased to announce that it has completed patient recruitment in the Scandinavian multi-center pivotal trial of 180 patients to investigate the patented Cooral® System for prevention of Oral Mucositis, one of the most debilitating side-effects of both standard and high-dose chemotherapeutic oncology treatments.
Per- and polyfluorinated alkyl substances are man-made chemicals that are useful in a variety of industries because of their durability, but do not naturally break down in the environment or human body.
› Verified 3 days ago
Ori Drory, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 330 E Warwick Dr, Alma, MI 48801 Phone: 989-629-8140 | |
Mr. Gregory Brian Bechill, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1910 Pine Ave, Alma, MI 48801 Phone: 989-463-3101 Fax: 989-463-2824 | |
Robert Reichmann, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 330 E Warwick Dr, Alma, MI 48801 Phone: 989-629-8140 Fax: 989-629-8145 | |
Dr. Maria K Klahre, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 647 W Warwick Dr, Alma, MI 48801 Phone: 906-284-7071 | |
Michelle Nelson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 330 E Warwick Dr, Alma, MI 48801 Phone: 989-629-8140 Fax: 989-629-8145 | |
Sarala Masti, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1910 Pine Ave, Alma, MI 48801 Phone: 989-463-3101 | |
Dr. Tyler Williams, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 300 E Warwick Dr, Alma, MI 48801 Phone: 989-839-1644 Fax: 989-839-3029 |